1. Hladnik U, Nyhan WL, Bertelli M. Variable expression of HPRT deficiency in 5 members of a family with the same mutation. Archives of neurology. 2008; 65(9): 1240-3. doi: 10.1001/archneur.65.9.1240. [
DOI:10.1001/archneur.65.9.1240]
2. Chandekar P, Madke B, Kar S, Yadav N. Lesch-nyhan syndrome in an Indian child. Indian journal of dermatology. 2015; 60(3): 298-300. doi: 10.4103/0019-5154.156392. [
DOI:10.4103/0019-5154.156392]
3. Torres RJ, Puig JG. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet journal of rare diseases. 2007; 2 (1): 48. doi.org/10.1186/1750-1172-2-48 [
DOI:10.1186/1750-1172-2-48]
4. Engle SJ, Womer DE, Davies PM, Boivin G, Sahota A, Simmonds HA, et al. HPRT-APRT-deficient mice are not a model for Lesch-Nyhan syndrome. Human molecular genetics. 1996; 5(10): 1607-10. [
DOI:10.1093/hmg/5.10.1607]
5. Torres RJ, Prior C, Puig JG. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism. 2007; 56(9): 1179-86. [
DOI:10.1016/j.metabol.2007.04.013]
6. Wang L-L, Li Y, Zhou S-F. Prediction of deleterious non-synonymous single nucleotide polymorphisms of genes related to ethanol-induced toxicity. Toxicology letters. 2009; 187(2): 99-114. doi: 10.1016/j.toxlet.2009.02.007. [
DOI:10.1016/j.toxlet.2009.02.007]
7. Bao L, Cui Y. Functional impacts of non-synonymous single nucleotide polymorphisms: Selective constraint and structural environments. FEBS letters. 2006; 580(5): 1231-4. DOI:10.1016/j.febslet.2006.01.035. [
DOI:10.1016/j.febslet.2006.01.035]
8. Chasman D, Adams RM. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. Journal of molecular biology. 2001;307(2):683-706. DOI:10.1006/jmbi.2001.4510. [
DOI:10.1006/jmbi.2001.4510]
9. Jordan DM, Ramensky VE, Sunyaev SR. Human allelic variation: perspective from protein function, structure, and evolution. Current opinion in structural biology. 2010; 20(3): 342-50. doi: 10.1016/j.sbi.2010.03.006. [
DOI:10.1016/j.sbi.2010.03.006]
10. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. Journal of molecular biology. 1990; 215(3): 403-10. DOI:10.1016/S0022-2836(05)80360-2. [
DOI:10.1016/S0022-2836(05)80360-2]
11. Gish W, States DJ. Identification of protein coding regions by database similarity search. Nature genetics. 1993; 3(3): 266-72. [
DOI:10.1038/ng0393-266]
12. Boguski MS, Lowe TM, Tolstoshev CM. dbEST—database for "expressed sequence tags". Nature genetics. 1993; 4(4): 332-3. [
DOI:10.1038/ng0893-332]
13. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic acids research. 2003; 31(13): 3812-4. [
DOI:10.1093/nar/gkg509]
14. Ramensky V, Bork P, Sunyaev S. Human non‐synonymous SNPs: server and survey. Nucleic acids research. 2002; 30(17): 3894-900. [
DOI:10.1093/nar/gkf493]
15. Fu R, Ceballos-Picot I, Torres RJ, Larovere LE, Yamada Y, Nguyen KV, et al. Genotype–phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain. 2014;137(5):1282-303. doi: 10.1093/brain/awt202. [
DOI:10.1093/brain/awt202]
16. Monzani PS, Trapani S, Thiemann OH, Oliva G. Crystal structure of Leishmania tarentolae hypoxanthine-guanine phosphoribosyltransferase. BMC structural biology. 2007;7(1): 59. [
DOI:10.1186/1472-6807-7-59]
17. Baba S, Saito T, Yamada Y, Takeshita E, Nomura N, Yamada K, et al. Novel mutation in HPRT1 causing a splicing error with multiple variations. Nucleosides, Nucleotides and Nucleic Acids. 2017; 36(1): 1-6. doi: 10.1080/15257770.2016.1163381. [
DOI:10.1080/15257770.2016.1163381]
18. Thumfart J, Weschke B, Ringe H, Weinhold N, Müller D. Acute renal failure unmasking Lesch-Nyhan disease in a patient with tuberous sclerosis complex. European Journal of Paediatric Neurology. 2016; 20(4): 649-51. doi: 10.1016/j.ejpn.2016.04.014. [
DOI:10.1016/j.ejpn.2016.04.014]
19. Keebaugh AC, Sullivan RT, Thomas JW, Program NCS. Gene duplication and inactivation in the HPRT gene family. Genomics. 2007; 89(1): 134-42. DOI:10.1016/j.ygeno.2006.07.003. [
DOI:10.1016/j.ygeno.2006.07.003]
20. Flier JS, Moore MJ, Wilson JM, Young AB, Kelley WN. Hypoxanthine-guanine phosphoribosyltransferase deficiency: The molecular basis of the clinical syndromes. New England Journal of Medicine. 1983; 309(15): 900-10. [
DOI:10.1056/NEJM198310133091507]
21. Duan J, Nilsson L, Lambert B. Structural and functional analysis of mutations at the human hypoxanthine phosphoribosyl transferase (HPRT1) locus. Human mutation. 2004; 23(6): 599-611. [
DOI:10.1002/humu.20047]
22. Balendiran GK, Molina J, Xu Y, Torres‐Martinez J, Stevens R, Focia PJ, et al. Ternary complex structure of human HGPRTase, PRPP, Mg2+, and the inhibitor HPP reveals the involvement of the flexible loop in substrate binding. Protein Science. 1999; 8(5): 1023-31. DOI:10.1110/ps.8.5.1023. [
DOI:10.1110/ps.8.5.1023]
23. Naderi M, Gharaei R, Soleymani-Nejadian E, Samadian E. In Silico survey of functional coding variants in human AEG-1 gene. Egyptian Journal of Medical Human Genetics. 2013;14(4):419-22. [
DOI:10.1016/j.ejmhg.2013.08.002]